Risk management in the treatment of type 2 diabetes with pioglitazone

INTRODUCTION: Type 2 diabetes mellitus is one of the most important cardiovascular risk factors. Insulin-resistance represents the common mechanism that leads to type 2 diabetes in obese subjects. Pioglitazone is an insulin-sensitizing agent available for treatment of type 2 diabetes. Large clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Derosa, Giuseppe, Salvadeo, Sibilla AT
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048017/
https://www.ncbi.nlm.nih.gov/pubmed/21437118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048017/
https://www.ncbi.nlm.nih.gov/pubmed/21437118

Ejemplares similares